Allergan files rebuttal to Valeant earnings
October 20, 2014 at 15:13 PM EDT
Allergan Inc. filed a rebuttal Monday to Valeant’s reported earnings in a filing with the Securities and Exchange Commission
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.